Discover

Donna Dickenson

Personal Information

Born January 1, 1946 (80 years old)
Also known as: D. L. Dickenson
16 books
0.0 (0)
9 readers

Description

There is no description yet, we will add it soon.

Books

Newest First

Body Shopping

0.0 (0)
0

From the Publisher: "In Body Shopping, award-winning writer Donna Dickenson makes a case against the new-found rights of businesses to harvest body parts and gain exclusive profit from the resulting products and processes. To illustrate her case, she presents a series of compelling stories of individuals injured or abused by the increasingly rapacious biotechnology industry." Body Shopping offers a fresh, international, and completely up-to-date take on the evolving legal position, the historical long view, and the latest biomedical research-an approach that goes beyond a mere recital of horror stories to suggest a range of new strategies to bring the biotechnology industry to heel. The result is a gripping, powerful book that is essential reading for everyone from parents to philosophers, and from scientists to lawmakers-everyone who believes that no human should ever be reduced to the sum of their body parts.

Risk and Luck in Medical Ethics

0.0 (0)
0

"Risk and Luck in Medical Ethics examines the 'moral luck' paradox in greater detail, relating it to Kantian, consequentialist, and virtue based approaches to ethics. This revised edition applies the paradoxes of risk and luck to medical ethics, including timely discussion of risk and luck in the allocation of scarce health care resources, informed consent to treatment, decisions about withholding life sustaining treatment, psychiatry, reproductive ethics, genetic resting, and medical research and evidence based medicine."--Jacket.

Me Medicine Vs We Medicine

0.0 (0)
2

Personalized healthcare -- or what the award-winning author Donna Dickenson calls "Me Medicine" -- is radically transforming our longstanding "one-size-fits-all" model. Technologies such as direct-to-consumer genetic testing, pharmacogenetically developed therapies in cancer care, private umbilical cord blood banking, and neurocognitive enhancement claim to cater to an individual's specific biological character, and, in some cases, these technologies have shown powerful potential. Yet in others they have produced negligible or even negative results. Whatever is behind the rise of Me Medicine, it isn't just science. So why is Me Medicine rapidly edging out We Medicine, and how has our commitment to our collective health suffered as a result?